MeMed Awarded $2 Million Grant to Establish a First-of-Its-Kind Acute Care Digital and Physical Biobank

▤ Summary

MeMed received a $2 million national grant from the IIA to create an acute-care diagnostics and proteomics biobank as part of a nationwide AI R&D data infrastructure. The biobank will link acute-care biospecimens with clinical data and high-resolution immune profiling to accelerate development and regulatory validation of AI-driven in vitro diagnostics (AIVD) for high-risk, time-critical patients. MeMed intends the infrastructure to enable rapid discovery, validation, and FDA-grade development that bridges traditional IVDs to intelligent, real-time clinical decision support. The award strengthens MeMed's platform capabilities and is positioned to shorten timelines and costs for acute-care diagnostics innovation.

$ Funding

▦ Linked Companies